ArticleJBRA assisted reproduction2025
Monosodium glutamate is associated with dose-dependent reproductive toxicity and sperm dysfunction in male wistar rats.
Article in JBRA assisted reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMonosodium glutamate (E621) is widely used as a flavor enhancer and is added to many processed foods, often concealed by the label E621. Controversies exist regarding its safety, as most studies use high doses that are challenging to translate to human relevance. This study investigated the effects of chronic low-dose MSG administration, mimicking average daily human usage, on male Wistar rats' reproductive function.
methodsThirty rats were divided into five groups (n=6): Group A (control, 1 ml distilled water) and Groups B, C, D, and E, receiving MSG doses of 30 mg/kg, 100 mg/kg, 300 mg/kg, and 1000 mg/kg body weight, respectively, for 30 days. Parameters measured included body weight, testicular weight, and semen analysis (sperm concentration, morphology, and motility).
resultsBody weight increased significantly in MSG-treated groups, particularly at higher doses (240±20 g for 300 mg/kg and 260±25 g for 1000 mg/kg). Gonadosomatic Index (GSI) rose dose-dependently, while testicular weight declined in higher-dose groups (1.2±0.1g at 1000 mg/kg). Sperm concentration reduced from 80±5 million/ml (control) to 30±2 million/ml (1000 mg/kg), and normal sperm morphology dropped from 76% to 58%. Defects in sperm head, neck, and tail increased with dose, and motility showed a marked decline, with fast progressive sperm decreasing to 39% (1000 mg/kg) and non-motile sperm rising to 51%.
conclusionsThese findings suggest that chronic low-dose MSG exposure negatively impacts male reproductive health, emphasizing the need to assess dietary MSG's long-term risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.